Answers are grounded in this paper and cite their sources.
Modifications to hinge and spacer regions improve structural stability and anti-tumor efficacy in CAR T cells.
Abstract Background Genetically engineered T cells expressing chimeric antigen receptors (CARs) have demonstrated remarkable therapeutic efficacy against refractory and relapsed acute lymphoblastic leukemia (ALL) and lymphomas. However, to achieve a stable conformation that enhances cytolytic potency and mitigates redundant activation of CAR T cells, optimal CAR functionality requires structural fine-tuning. Methods Here, we modified hinge and spacer regions in CARs and systematically evaluated their relative structural stabilities. The novel methodology utilized included characterization of soluble CARs through assessments of structural integrity, molecular dispersity, and thermal unfolding. Results The modified CARs showed subtle differences in cytolytic capacity in vitro, however, contrasted markedly with significantly improved tumor cell control observed in animal models. Our targeted modifications to the dimer-forming domains successfully attenuated CAR fragmentation and substantially enhanced thermal stability. Notably, these structurally stabilized CARs significantly prolonged survival in an in vivo ‘stress test’, with an increase from 33% to 71% in survival compared to original, non-stabilized CAR construct. Conclusions Our findings elucidate critical structure-function relationships in CAR design, particularly regarding the pivotal roles of hinge and spacer domains in maintaining receptor stability. The correlation between enhanced structural stability and improved anti-tumor efficacy provides mechanistic insights that advance CAR T cell modalities.
No takes yet. Share an insight, caveat, or question.
Koski et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: